On the upside
Hong Kong software and online services company CDC (Nasdaq: CHINA) will make an initial public offering of 4.8 million American Depositary Shares of its subsidiary CDC Software.
Analysts expect Human Genome Sciences (Nasdaq: HGSI) to report disappointing results from its lupus drug trial on Monday but speculators sent the stock price up.
Although MGIC Investment (NYSE: MTG) widened second quarter losses, revenue rose to top estimates.
On the downside
Fitch Ratings slashed the rating of UCBH (Nasdaq: UCBH) further into speculative territory after the parent of United Commercial Bank suspended dividends on both its common and preferred stock.
Ivanhoe Mines (NYSE: IVN) warned that there will be further discussions with the Mongolian parliament over development of its Oyu Tolgoi mine.
CapitalSource (NYSE: CSE) will offer 17.5 million common shares at $4.10 per share.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by a more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks rose 6 points to 522.
